Erratum to: Med Oncol (2015) 32:12 DOI 10.1007/s12032-014-0460-3
An error was inadvertently missed by the author in the original publication, and it has been corrected with this erratum.
“PFS of female patients was 6.2 (0–14.4)” should be replaced with “3.4 (0–8.8)” in Table 2 on page 5.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s12032-014-0460-3.
Rights and permissions
About this article
Cite this article
Hacibekiroglu, I., Kodaz, H., Erdogan, B. et al. Erratum to: Single-agent bevacizumab is an effective treatment in recurrent glioblastoma. Med Oncol 32, 119 (2015). https://doi.org/10.1007/s12032-015-0482-5
Published:
DOI: https://doi.org/10.1007/s12032-015-0482-5